Headinvest LLC cut its position in shares of Dentsply International Inc. (NASDAQ:XRAY) by 0.5% during the second quarter, Holdings Channel reports. The firm owned 98,921 shares of the company’s stock after selling 455 shares during the period. Dentsply International makes up 2.3% of Headinvest LLC’s holdings, making the stock its 10th largest position. Headinvest LLC’s holdings in Dentsply International were worth $6,137,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the stock. Norges Bank acquired a new stake in shares of Dentsply International during the fourth quarter worth $85,870,000. Chevy Chase Trust Holdings Inc. raised its stake in shares of Dentsply International by 74.2% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 212,862 shares of the company’s stock worth $13,118,000 after buying an additional 90,667 shares during the last quarter. Raymond James Trust N.A. raised its stake in shares of Dentsply International by 23.8% in the first quarter. Raymond James Trust N.A. now owns 5,511 shares of the company’s stock worth $339,000 after buying an additional 1,061 shares during the last quarter. First Manhattan Co. raised its stake in shares of Dentsply International by 581.9% in the first quarter. First Manhattan Co. now owns 9,778 shares of the company’s stock worth $602,000 after buying an additional 8,344 shares during the last quarter. Finally, Chesley Taft & Associates LLC purchased a new stake in shares of Dentsply International during the first quarter worth approximately $436,000. Institutional investors own 94.58% of the company’s stock.

Dentsply International Inc. (NASDAQ:XRAY) traded up 0.20% during trading on Thursday, hitting $60.01. The stock had a trading volume of 2,069,028 shares. The stock has a 50 day moving average of $60.68 and a 200 day moving average of $61.56. Dentsply International Inc. has a one year low of $49.48 and a one year high of $65.83. The firm has a market capitalization of $13.98 billion, a P/E ratio of 28.16 and a beta of 1.40.

Dentsply International (NASDAQ:XRAY) last posted its earnings results on Friday, August 5th. The company reported $0.76 EPS for the quarter, beating the consensus estimate of $0.70 by $0.06. The firm earned $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. Dentsply International had a return on equity of 9.18% and a net margin of 11.99%. The business’s quarterly revenue was up 46.4% on a year-over-year basis. During the same period last year, the company earned $0.73 earnings per share. Equities research analysts expect that Dentsply International Inc. will post $2.76 earnings per share for the current fiscal year.

The company also recently announced a dividend, which will be paid on Friday, October 14th. Shareholders of record on Friday, September 30th will be given a $0.0775 dividend. The ex-dividend date is Wednesday, September 28th. Dentsply International’s dividend payout ratio is presently 14.49%.

A number of brokerages recently commented on XRAY. Piper Jaffray Cos. began coverage on Dentsply International in a research report on Monday, June 13th. They issued an “overweight” rating and a $70.00 price objective for the company. Credit Suisse Group AG reiterated a “buy” rating on shares of Dentsply International in a research report on Sunday, June 5th. Zacks Investment Research lowered Dentsply International from a “buy” rating to a “hold” rating in a research report on Monday, August 8th. Barrington Research lowered Dentsply International from an “outperform” rating to a “market perform” rating in a research report on Monday, August 8th. Finally, Jefferies Group reiterated a “buy” rating on shares of Dentsply International in a research report on Wednesday, August 17th. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $67.00.

In other Dentsply International news, VP Rainer Berthan sold 5,000 shares of the stock in a transaction dated Tuesday, September 6th. The stock was sold at an average price of $61.12, for a total value of $305,600.00. Following the completion of the transaction, the vice president now directly owns 34,370 shares in the company, valued at $2,100,694.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Maureen J. Macinnis sold 45,100 shares of the stock in a transaction dated Thursday, August 25th. The shares were sold at an average price of $60.55, for a total value of $2,730,805.00. Following the completion of the transaction, the senior vice president now owns 36,730 shares of the company’s stock, valued at $2,224,001.50. The disclosure for this sale can be found here. 2.20% of the stock is owned by company insiders.

About Dentsply International

DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.

5 Day Chart for NASDAQ:XRAY

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dentsply International Inc. (NASDAQ:XRAY).

Receive News & Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.